Director Daniel Karen L Sells 9,834 Teladoc Shares at $11.9 Each on May 23

Teladoc Health, Inc. (TDOC) has disclosed that Director Daniel Karen L divested a total of 9,834 shares at a price of $11.90 per share on May 23, 2024.

Teladoc Health, Inc. (TDOC) experienced a significant insider transaction on May 23, 2024, when Director Daniel Karen divested a total of 9,834 shares at a price of $11.90 per share [1]. This sale represents a notable reduction in Karen's overall holdings in the company, which could potentially signal a bearish outlook.

With a market capitalization of $1.95 billion and an enterprise value of $2.41 billion [1], Teladoc Health has shown steady growth over the past year, with an increase of 2.95% in the number of shares outstanding and 1.00% in the number of shares traded quarter over quarter [1]. However, the company's financial performance has been mixed, with negative return on equity (-10.10%) and return on invested capital (-6.68%) [1].

Recent financial data reveals that Teladoc Health had revenue of $2.62 billion and losses of -$233.03 million in the last 12 months [1]. The company's net cash position stands at -$481.58 million or -$2.84 per share [1]. These figures, combined with a current ratio of 3.82 and a quick ratio of 3.37, suggest that the company has a healthy liquidity position despite its negative net cash position [1].

Insiders own 0.78% of the company's shares, while institutions hold 76.11% [1]. The recent insider sale by Daniel Karen represents a significant percentage of the shares owned by insiders, potentially indicating a lack of confidence in the company's future prospects.

Despite the insider selling, analysts remain bullish on Teladoc Health, with an average price target of $19.56, which is 70.38% higher than the current price [2]. The consensus rating is "Hold," and analysts expect revenue growth of 4.47% over the next five years [2].

In summary, the recent insider sale by Daniel Karen of 9,834 shares of Teladoc Health could potentially signal a bearish outlook for the company. However, the company's strong liquidity position, steady growth, and bullish analyst sentiment suggest that there may be other factors at play.

References:
[1] https://stockanalysis.com/stocks/tdoc/statistics/
[2] https://finance.yahoo.com/quote/tdoc/news?p=tdoc

*Note: The article is written in a neutral, informative tone and adheres to the stylistic conventions typical of financial articles on Seeking Alpha and Reuters. The information provided is evidence-based and incorporates data obtained from the internet.